Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunter New England Local Health District (HNELHD) is a major public healthcare provider serving the Hunter, New England, and Lower Mid North Coast regions of New South Wales, Australia. As one of the largest health districts in the state, it provides a comprehensive range of services including emergency medicine, surgery, mental health, and community health to a population of nearly one million people. The organization operates several major referral hospitals, most notably John Hunter Hospital and the Calvary Mater Newcastle, which serve as centers for specialized care and clinical excellence. HNELHD is a significant contributor to medical research and education, maintaining a close partnership with the University of Newcastle and the Hunter Medical Research Institute. Through these collaborations, the district facilitates numerous clinical trials and translational research projects across diverse therapeutic areas such as oncology and neuroscience. The health service is committed to improving health outcomes for its diverse population, with a particular focus on integrated care and Aboriginal health initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunter New England Health Service.